IT1391023B1 - USE OF BUTIRRIC GAMMA-AMINO ACID (GABA) OR A BUTY-ENHANCED BIOMASS OF BUTIRRIC GAMMA-AMINO ACID (GABA) FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS. - Google Patents

USE OF BUTIRRIC GAMMA-AMINO ACID (GABA) OR A BUTY-ENHANCED BIOMASS OF BUTIRRIC GAMMA-AMINO ACID (GABA) FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS.

Info

Publication number
IT1391023B1
IT1391023B1 ITRM2008A000519A ITRM20080519A IT1391023B1 IT 1391023 B1 IT1391023 B1 IT 1391023B1 IT RM2008A000519 A ITRM2008A000519 A IT RM2008A000519A IT RM20080519 A ITRM20080519 A IT RM20080519A IT 1391023 B1 IT1391023 B1 IT 1391023B1
Authority
IT
Italy
Prior art keywords
butirric
gaba
gamma
amino acid
buty
Prior art date
Application number
ITRM2008A000519A
Other languages
Italian (it)
Inventor
Barbara Marzani
Anna Benedusi
Giammaria Giuliani
Marco Gobbetti
Antonio Limitone
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Spa filed Critical Giuliani Spa
Priority to ITRM2008A000519A priority Critical patent/IT1391023B1/en
Publication of ITRM20080519A1 publication Critical patent/ITRM20080519A1/en
Application granted granted Critical
Publication of IT1391023B1 publication Critical patent/IT1391023B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/005—Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITRM2008A000519A 2008-10-01 2008-10-01 USE OF BUTIRRIC GAMMA-AMINO ACID (GABA) OR A BUTY-ENHANCED BIOMASS OF BUTIRRIC GAMMA-AMINO ACID (GABA) FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS. IT1391023B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITRM2008A000519A IT1391023B1 (en) 2008-10-01 2008-10-01 USE OF BUTIRRIC GAMMA-AMINO ACID (GABA) OR A BUTY-ENHANCED BIOMASS OF BUTIRRIC GAMMA-AMINO ACID (GABA) FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM2008A000519A IT1391023B1 (en) 2008-10-01 2008-10-01 USE OF BUTIRRIC GAMMA-AMINO ACID (GABA) OR A BUTY-ENHANCED BIOMASS OF BUTIRRIC GAMMA-AMINO ACID (GABA) FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS.

Publications (2)

Publication Number Publication Date
ITRM20080519A1 ITRM20080519A1 (en) 2010-04-02
IT1391023B1 true IT1391023B1 (en) 2011-10-27

Family

ID=40637210

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM2008A000519A IT1391023B1 (en) 2008-10-01 2008-10-01 USE OF BUTIRRIC GAMMA-AMINO ACID (GABA) OR A BUTY-ENHANCED BIOMASS OF BUTIRRIC GAMMA-AMINO ACID (GABA) FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS.

Country Status (1)

Country Link
IT (1) IT1391023B1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19712977A1 (en) * 1997-03-27 1998-10-01 Laves Arzneimittel Gmbh Use of gamma-aminobutyric acid
AUPO821097A0 (en) * 1997-07-25 1997-08-14 Cultor Ltd. A prophylactic
JP2004313032A (en) * 2003-04-14 2004-11-11 Sadaji Yokoyama Method for producing functional raw material
WO2008023665A1 (en) * 2006-08-21 2008-02-28 Sapporo Breweries Limited Bacterial strain having anti-allergic activity and immunostimulating activity, and beverage, food, anti-allergic agent and immunostimulating agent comprising the bacterial strain
WO2008023662A1 (en) * 2006-08-21 2008-02-28 Sapporo Breweries Limited Bacterial strain having immunostimulating activity, and beverage, food and immunostimulating agent comprising the bacterial strain
ITRM20070398A1 (en) * 2007-07-17 2009-01-18 Giuliani Spa PROCEDURE FOR THE PREPARATION OF BUTIRRIC GAMMA-AMINO ACID (GABA) THROUGH LACTIC BACTERIA (LAB) ON AGRO-FOOD SURPLUS.

Also Published As

Publication number Publication date
ITRM20080519A1 (en) 2010-04-02

Similar Documents

Publication Publication Date Title
SMP200900085B (en) 3-imidazolyl-indoles for the treatment of malolysiseproliferative.
CR10693A (en) ENANTIOMERICALLY PURE PHOSPHOINDOLES AS HIV INHIBITORS
DK2502172T3 (en) Hypoglycemic treatment systems
BRPI1011886A2 (en) solution containing hypochlorous acid and methods for its use.
AP2010005480A0 (en) Small molecule inhibitors for the treatment or prevention of denque virus infection.
BRPI0906141A2 (en) reduced pressure treatment system
AP2012006227A0 (en) Derivatives of purine or deazapurine useful for the treatment of inter, alia viral, infections.
DK2142186T3 (en) Use of oligomers of lactic acid in the treatment of gynecological infections
SMT201500157B (en) Pyrazolylaminopyridines as fak inhibitors
HK1144553A1 (en) Use of an acetylsalicylic acid salt for the treatment of viral infections
BRPI0909974A2 (en) self-retaining nut.
BRPI0923796A2 (en) antiviral compounds, treatment and assay
IT1400714B1 (en) PROCESS AND INTERMEDIATE FOR THE PREPARATION OF AN ACTIVE PRINCIPLE.
BR112012004676A2 (en) method of treating orotomixoviral infections.
BRPI0920996A2 (en) use of polyols and cyanohexane polycarboxylic acid derivatives to remove dust from construction chemicals.
SMT201600403B (en) COMPOSITIONS FOR THE TREATMENT OF ROSACEA INCLUDING CHITOSAN AND AN AMMIDE OF A DICARBOSSYLIC ACID
IT1396812B1 (en) DEVICE FOR THE TRANSPORT OF MEDICAL INSTRUMENTS.
IT1391108B1 (en) PROCESS FOR THE PREPARATION OF ETHYLIDENNORBORNENE.
FR2915997B1 (en) ANTI-GRAFFITI TREATMENT.
BR112012002267A2 (en) compounds for the treatment of inflammation.
IT1393778B1 (en) PROCEDURE FOR WASTE TREATMENT.
IT1391023B1 (en) USE OF BUTIRRIC GAMMA-AMINO ACID (GABA) OR A BUTY-ENHANCED BIOMASS OF BUTIRRIC GAMMA-AMINO ACID (GABA) FOR THE PREVENTION AND / OR TREATMENT OF INFECTIONS.
DE602006019048D1 (en) EDDH-containing descaling solutions
ZA201100468B (en) The treatment of helminthic infections
BR112012003044A2 (en) cathepsin inhibitors c.